Gene · 58191
Papers4,127
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 4,127
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Focused ultrasound mitigates pathology and improves spatial memory in Alzheimer's mice and patients. | Theranostics | 2023 | 37554284 | PubTator, text mining | PubMed |
| Protein Biomarkers of Early Menopause and Incident Cardiovascular Disease. | J Am Heart Assoc | 2023 | 37548169 | PubTator, text mining | PubMed |
| Integrated analysis of single-cell and bulk RNA-seq establishes a novel signature for prediction in gastric cancer. | World J Gastrointest Oncol | 2023 | 37546563 | PubTator, text mining | PubMed |
| A novel metabolic subtype with S100A7 high expression represents poor prognosis and immuno-suppressive tumor microenvironment in bladder cancer. | BMC Cancer | 2023 | 37543645 | PubTator, text mining | PubMed |
| Advances in radiotherapy and immunity in hepatocellular carcinoma. | J Transl Med | 2023 | 37542324 | PubTator, text mining | PubMed |
| Prognostic significance and mechanisms of CXCL genes in clear cell renal cell carcinoma. | Aging (Albany NY) | 2023 | 37540227 | PubTator, text mining | PubMed |
| Identification and characterization of putative biomarkers and therapeutic axis in Glioblastoma multiforme microenvironment. | Front Cell Dev Biol | 2023 | 37538397 | PubTator, text mining | PubMed |
| CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers. | Science | 2023 | 37535729 | PubTator, text mining | PubMed |
| Spatiotemporally organized immunomodulatory response to SARS-CoV-2 virus in primary human broncho-alveolar epithelia. | iScience | 2023 | 37520727 | PubTator, text mining | PubMed |
| Case Report: Intervention of radiotherapy improves the prognosis of rectal squamous cell carcinoma with high PD-L1 expression and enable patients to obtain NED status. | Front Immunol | 2023 | 37520582 | PubTator, text mining | PubMed |
| Progress of regulatory RNA in small extracellular vesicles in colorectal cancer. | Front Cell Dev Biol | 2023 | 37519298 | PubTator, text mining | PubMed |
| Thirty-five years since the discovery of chemotactic cytokines, interleukin-8 and MCAF: A historical overview. | Proc Jpn Acad Ser B Phys Biol Sci | 2023 | 37518010 | PubTator, text mining | PubMed |
| Evaluation of Cisplatin-Induced Acute Renal Failure Amelioration Using Fondaparinux and Alteplase. | Pharmaceuticals (Basel) | 2023 | 37513824 | PubTator, text mining | PubMed |
| The Role of Genetics and Epigenetic Regulation in the Pathogenesis of Osteoarthritis. | Int J Mol Sci | 2023 | 37511413 | PubTator, text mining | PubMed |
| The Metallodrug BOLD-100 Is a Potent Inhibitor of SARS-CoV-2 Replication and Has Broad-Acting Antiviral Activity. | Biomolecules | 2023 | 37509131 | PubTator, text mining | PubMed |
| Infection Meets Inflammation: N6-Methyladenosine, an Internal Messenger RNA Modification as a Tool for Pharmacological Regulation of Host-Pathogen Interactions. | Biomolecules | 2023 | 37509095 | PubTator, text mining | PubMed |
| Insight into Cancer Immunity: MHCs, Immune Cells and Commensal Microbiota. | Cells | 2023 | 37508545 | PubTator, text mining | PubMed |
| Secretome-based acellular therapy of bone marrow-derived mesenchymal stem cells in degenerative and immunological disorders: A narrative review. | Heliyon | 2023 | 37496898 | PubTator, text mining | PubMed |
| Single-cell analyses implicate ascites in remodeling the ecosystems of primary and metastatic tumors in ovarian cancer. | Nat Cancer | 2023 | 37488416 | PubTator, text mining | PubMed |
| A single-cell CRISPRi platform for characterizing candidate genes relevant to metabolic disorders in human adipocytes. | Am J Physiol Cell Physiol | 2023 | 37486064 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58191/papers?page=25